HFpEF now accounts for a majority of heart failure cases, highlighting the importance of ensuring both primary care providers and dedicated heart teams know as much about this topic as possible. 

If great power obligates its wielder to exercise great responsibility, those advancing AI in healthcare are up to their necks in duty.

The recommendation is based on an analysis of mortality data from 415,000 U.S. women spanning 2011-2020. 

After high-risk medical devices go through the initial FDA approval process, it is relatively easy for manufacturers to get updates to those devices approved. New evidence suggests that this policy could be leading to more recalls, especially among cardiovascular devices.  

That’s according to an award-winning scientific online poster presented this week during the American Roentgen Ray Society’s annual meeting being held in Honolulu, Hawaii.

The hope is that the technique could lead to earlier detection of diseases by simultaneously identifying structural and functional abnormalities that standard ultrasound imaging methods alone cannot.

GE Healthcare received clearance from the U.S. Food and Drug Administration (FDA) for its patient monitoring platform, Carescape Canvas.

Despite being widely praised by many of its users, ChatGPT recently left much to be desired by experts who compared the chatbot’s medical writing alongside that of seasoned professionals.